Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $8.74 Analyst target: $23.29 Upside: 166.48%
Benitec Biopharma Inc., a developing biotechnology company, is focused on the development of new genetic drugs. The company is headquartered in Hayward, California.
See the full interactive analysis & chart →Informational only — not investment advice.